Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial
Authors
Keywords
-
Journal
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-10-20
DOI
10.1111/jth.14662
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Apixaban and Rivaroxaban in Patients With Acute Venous Thromboembolism
- (2019) Dalene M. Bott-Kitslaar et al. MAYO CLINIC PROCEEDINGS
- Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)
- (2018) Annie M. Young et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH
- (2018) A. A. Khorana et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
- (2018) Gary E. Raskob et al. NEW ENGLAND JOURNAL OF MEDICINE
- NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018
- (2018) Michael B. Streiff et al. Journal of the National Comprehensive Cancer Network
- Apixaban and dalteparin in active malignancy associated venous thromboembolism
- (2017) Charles Loprinzi et al. THROMBOSIS AND HAEMOSTASIS
- Direct Oral Anticoagulants in Patients With VTE and Cancer
- (2015) Maria Cristina Vedovati et al. CHEST
- Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer
- (2015) Agnes Y. Y. Lee et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH
- (2015) S. Kaatz et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study
- (2014) C. E. Chee et al. BLOOD
- Oral Apixaban for the Treatment of Acute Venous Thromboembolism
- (2013) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer effect on periprocedural thromboembolism and bleeding in anticoagulated patients
- (2012) A. J. Tafur et al. ANNALS OF ONCOLOGY
- Apixaban in Patients with Atrial Fibrillation
- (2011) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Periprocedural Anticoagulation Management of Patients With Venous Thromboembolism
- (2010) Robert D. McBane et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Bleeding complications associated with anticoagulant therapy in patients with cancer
- (2010) Javier Trujillo-Santos et al. THROMBOSIS RESEARCH
- Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients
- (2009) S. SCHULMAN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Development and validation of a predictive model for chemotherapy-associated thrombosis
- (2008) A. A. Khorana et al. BLOOD
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started